{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:21:26Z","timestamp":1776388886170,"version":"3.51.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.canlet.2004.11.004","type":"journal-article","created":{"date-parts":[[2004,12,29]],"date-time":"2004-12-29T05:13:36Z","timestamp":1104297216000},"page":"275-282","source":"Crossref","is-referenced-by-count":45,"title":["CYP3A5 genotypes and risk of oesophageal cancer in two South African populations"],"prefix":"10.1016","volume":"225","author":[{"given":"Collet","family":"Dandara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robea","family":"Ballo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Iqbal Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2004.11.004_bib1","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0959-8049(01)00267-2","article-title":"Cancer burden in the year 2000. The global picture","volume":"37","author":"Parkin","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2004.11.004_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/15216540212643","article-title":"Oesophageal cancer in Africa","volume":"53","author":"Hendricks","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.canlet.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2307\/3435014","article-title":"Discovery and occurrence of the fumonisins: a historical pespective","volume":"109","author":"Marasas","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.canlet.2004.11.004_bib4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.278.5340.1068","article-title":"Environment and cancer: who are susceptible?","volume":"278","author":"Perera","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.canlet.2004.11.004_bib5","first-page":"1013","article-title":"Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1 and M1 and cytochrome P450 2E1","volume":"7","author":"Lin","year":"1998","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/mi.3.4.194","article-title":"Cytochromes P450, drugs, and diseases","volume":"3","author":"Guengerich","year":"2003","journal-title":"Mol. Intervent."},{"key":"10.1016\/j.canlet.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/0264-6021:3380489","article-title":"Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus","volume":"338","author":"Strassburg","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2004.11.004_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.canlet.2004.11.004_bib9","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.canlet.2004.11.004_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1006\/bbrc.2001.4505","article-title":"Cloning and tissue distribution of a novel human cytochrome P450 of the CYP3A subfamily, CYP3A43","volume":"281","author":"Westlind","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/carcin\/20.2.243","article-title":"Characterisation of cytochrome P450 expression in human oesophageal mucosa","volume":"20","author":"Lechevrel","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2004.11.004_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.canlet.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterisation of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2004.11.004_bib14","unstructured":"Human Cytochrome P450 (CYP) Allele Nomenclature Committee Web site, Available at: http:\/\/www.imm.ki.se\/CYPalleles\/."},{"key":"10.1016\/j.canlet.2004.11.004_bib15","first-page":"928","article-title":"CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer","volume":"12","author":"Plummer","year":"2003","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2004.11.004_bib16","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/clinchem\/48.10.1668","article-title":"CYP3A5 variant allele frequencies in Dutch Caucasians","volume":"48","author":"van Schaik","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2004.11.004_bib17","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1111\/j.1572-0241.2001.05276.x","article-title":"Genetic polymorphism of N-acetyltransferase 2 in cases with esophageal cancer","volume":"96","author":"Shibuta","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canlet.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S1047-2797(03)00143-1","article-title":"N-Acetyltransferase 2 polymorphisms and interactions on risk of oesophageal cancer","volume":"13","author":"Lee","year":"2003","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.canlet.2004.11.004_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0163-7258(96)00006-X","article-title":"Fumonisins, mycotoxins and increasing importance: their nature and effects","volume":"70","author":"Dutton","year":"1996","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2004.11.004_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1382-6689(00)00040-5","article-title":"Effect of fumonisin B1 on rat hepatic P450 system","volume":"8","author":"Spotti","year":"2000","journal-title":"Environ. Toxicol. Pharm."},{"key":"10.1016\/j.canlet.2004.11.004_bib21","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.92.6.2384","article-title":"Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1","volume":"92","author":"Mcglynn","year":"1995","journal-title":"Proc. Natl Acad. Sci. (USA)"},{"key":"10.1016\/j.canlet.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(03)00337-9","article-title":"In vitro aflatoxin B1-induced p53 mutations","volume":"199","author":"Chan","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2004.11.004_bib23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1515\/CCLM.2002.167","article-title":"Genetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans","volume":"40","author":"Dandara","year":"2002","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.canlet.2004.11.004_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008571-200301000-00008","article-title":"Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A","volume":"13","author":"Dandara","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.canlet.2004.11.004_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1515\/CCLM.2003.090","article-title":"Allele frequencies for glutathione S-transferase and N-acetyltransferase 2 differ in African population groups and may be associated with oesophageal cancer or tuberculosis incidence","volume":"41","author":"Adams","year":"2003","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383504008614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383504008614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T01:37:28Z","timestamp":1586050648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383504008614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0304383504008614"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2004.11.004","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}